Physician profile
Lee L Pu
NPI 1629034558
$10,845.43
in general payments reported to CMS, 2019-2025
21 companies · $279 in 2025
The $279 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,443 · 2020: $2,183 · 2021: $878 · 2022: $1,464 · 2023: $2,456 · 2024: $2,142 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,984 · Food and Beverage: $1,893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,984.23 |
| Food and Beverage | $1,893.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,027.39 | 2023-2024 | |
| Musculoskeletal Transplant Foundation INC. | $2,109.73 | 2019-2023 | |
| Integra Lifesciences Corporation | $925.12 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Sientra, INC. | $772.49 | 2019-2022 | |
| Mentor Worldwide LLC | $368.82 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Axogen | $282.17 | 2019-2022 | |
| Allergan, INC. | $276.40 | 2020-2022 | |
| Tepha INC | $259.47 | 2019 | |
| Polarityte, INC. | $250.85 | 2019-2020 | |
| Innovation Technologies INC | $238.08 | 2022 | |
| Acell, INC. | $230.40 | 2019-2020 | |
| Tei Biosciences INC | $227.31 | 2019 | |
| Kerecis Limited | $144.64 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Baudax Bio INC. | $125.06 | 2021 | |
| Baxter Healthcare | $122.18 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $119.30 | 2020 | |
| Tela Bio, INC. | $111.10 | 2021 | |
| Kls-Martin L.P. | $93.75 | 2021 | |
| Vioptix INC | $88.91 | 2020 | |
| Kci USA, INC. | $36.25 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $36.01 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Pu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.